Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marc-Jens Kleppa

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Cells

PLoS genetics

PloS one

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Adrian Schwarzer, Matheus Pinto De Oliveira, Marc-Jens Kleppa, Scott D Slattery, Andy Anantha, Alan Cooper, Mark Hannink, Axel Schambach, Anneke Doerrie, Alexey Kotylarov, Matthias Gaestel, Todd Hembrough, Jedd Levine, Michael Luther, Michael Stocum, Linsey Stiles, David M Weinstock, Marc Liesa, Matthew J Kostura
Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1. Molecular cancer therapeutics (2023)
Tobias Maetzig, Anna Lieske, Nicole Dörpmund, Michael Rothe, Marc-Jens Kleppa, Violetta Dziadek, Jacob Jalil Hassan, Julia Dahlke, Dorit Borchert, Axel Schambach
Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding. Cells 11 (24) (2022)
Tobias Maetzig, Anna Lieske, Nicole Dörpmund, Michael Rothe, Marc-Jens Kleppa, Violetta Dziadek, Jacob Jalil Hassan, Julia Dahlke, Dorit Borchert, Axel Schambach
Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding. Cells 11 (24) (2022)
Tobias Maetzig, Anna Lieske, Nicole Dörpmund, Michael Rothe, Marc-Jens Kleppa, Violetta Dziadek, Jacob Jalil Hassan, Julia Dahlke, Dorit Borchert, Axel Schambach
Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding. Cells 11 (24) (2022)
Tobias Maetzig, Anna Lieske, Nicole Dörpmund, Michael Rothe, Marc-Jens Kleppa, Violetta Dziadek, Jacob Jalil Hassan, Julia Dahlke, Dorit Borchert, Axel Schambach
Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding. Cells 11 (24) (2022)
Jacob Jalil Hassan, Anna Lieske, Nicole Dörpmund, Denise Klatt, Dirk Hoffmann, Marc-Jens Kleppa, Olga S Kustikova, Maike Stahlhut, Adrian Schwarzer, Axel Schambach, Tobias Maetzig
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML. International journal of molecular sciences 22 (17) (2021)
Reginaldo Rivera-Reyes, Marc-Jens Kleppa, Andreas Kispert
Proteomic analysis identifies transcriptional cofactors and homeobox transcription factors as TBX18 binding proteins. PloS one 13 (8) (2018)
Tobias Bohnenpoll, Anna B Wittern, Tamrat M Mamo, Anna-Carina Weiss, Carsten Rudat, Marc-Jens Kleppa, Karin Schuster-Gossler, Irina Wojahn, Timo H-W Lüdtke, Mark-Oliver Trowe, Andreas Kispert
A SHH-FOXF1-BMP4 signaling axis regulating growth and differentiation of epithelial and mesenchymal tissues in ureter development. PLoS genetics 13 (8) (2017)

Marc-Jens Kleppa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marc-Jens Kleppa